BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.41.90//
CALSCALE:GREGORIAN
UID:32636338-3631-4030-b131-613765346438
BEGIN:VEVENT
UID:f291b49e5225b8766fee0bb2c198c1c141270526@swoogo.com
DTSTAMP:20260610T184259Z
DESCRIPTION:Join our discussion on IDEXX’s Cancer Dx™ test\, highlighting t
 he latest data and emerging insights surrounding this innovative liquid bi
 opsy for canine lymphoma. Lymphoma—one of the most common canine cancers—o
 ften presents variably and is frequently diagnosed late in the disease cou
 rse. Cancer Dx offers a blood-based approach designed to support earlier d
 etection\, diagnosis\, and monitoring. We'll also discuss how veterinary t
 eams can incorporate this new technology into wellness protocols as part o
 f cancer screening.
DTSTART:20260611T233000Z
DTEND:20260612T023000Z
LAST-MODIFIED:20260610T184259Z
LOCATION:Sakari Lounge\, 2605 Ingersoll Ave\, Des Moines\, IA 50312\, Unite
 d States
SEQUENCE:0
STATUS:CONFIRMED
SUMMARY:06.11.2026 Holland Des Moines IA Confidence in Cancer Care with IDE
 XX Cancer DX Testing
TRANSP:OPAQUE
X-ALT-DESC;FMTTYPE=text/html:<p><span style='font-size:12pt\;'><span style=
 'font-family:Aptos\, sans-serif\;'><span style='font-size:11pt\;'>Join our
  discussion on IDEXX’s Cancer Dx™ test\, highlighting the latest data and 
 emerging insights surrounding this innovative liquid biopsy for canine lym
 phoma. Lymphoma—one of the most common canine cancers—often presents varia
 bly and is frequently diagnosed late in the disease course. Cancer Dx offe
 rs a blood-based approach designed to support earlier detection\, diagnosi
 s\, and monitoring. We'll also discuss how veterinary teams can incorporat
 e this new technology into wellness protocols as part of cancer screening.
 </span></span></span></p>
BEGIN:VALARM
UID:31633633-6531-4665-b033-336336363139
ACTION:DISPLAY
DESCRIPTION:Join our discussion on IDEXX’s Cancer Dx™ test\, highlighting t
 he latest data and emerging insights surrounding this innovative liquid bi
 opsy for canine lymphoma. Lymphoma—one of the most common canine cancers—o
 ften presents variably and is frequently diagnosed late in the disease cou
 rse. Cancer Dx offers a blood-based approach designed to support earlier d
 etection\, diagnosis\, and monitoring. We'll also discuss how veterinary t
 eams can incorporate this new technology into wellness protocols as part o
 f cancer screening.
TRIGGER:-PT15M
END:VALARM
END:VEVENT
END:VCALENDAR
